新光药业：股东和丰投资拟减持不超3%公司股份

Core Viewpoint - The major shareholder of New Light Pharmaceutical (300519), He Feng Investment Co., Ltd., plans to reduce its stake by selling up to 4.8 million shares, representing no more than 3% of the company's total equity [1] Group 1 - He Feng Investment holds a 15.74% stake in New Light Pharmaceutical [1] - The reduction will occur through centralized bidding or block trading methods [1] - The total number of shares to be sold is capped at 4.8 million [1]